-transparent.png){kind=logo}
Myocardial ventricular Na, K-ATPase activity of normotensive rats was compared with that of healthy rats with chronic benign one-kidney, one-clip hypertension. The yield of protein (mg/g wet wt left plus right ventricles) in microsomal and sarcolemmal membrane fractions was the same for both normotensive and hypertensive rat ventricles. However, the yield of protein (mg/ventricle) was 26% greater in the hypertensive relative to the normotensive animals, consistent with the presence of hypertrophy, as also indicated by an increase in the ratio of ventricular to body weight and a shift in the isomyosin composition. Na, K-ATPase activity, sodium-dependent phosphorylation and ouabain binding were significantly (P less than 0.05) decreased (by 20%, 40%, and 45%, respectively) in the hypertensive rat ventricles when the data were expressed in units/g tissue wet weight. However, when expressed in units per ventricle, values in normotensive and hypertensive animals were similar. The molecular activity or turnover number of ventricular (and also renal) Na, K-ATPase activity was the same in both groups of animals. These results suggest that the decrease in myocardial specific Na, K-ATPase activity in the rat made hypertensive by removing one kidney and constricting the renal artery of the other kidney is related to the presence of cardiac hypertrophy.
K R Whitmer, and
J H Lee, and
A F Martin, and
L K Lane, and
S W Lee, and
A Schwartz, and
H W Overbeck, and
E T Wallick
August 1983,
The American journal of physiology,
K R Whitmer, and
J H Lee, and
A F Martin, and
L K Lane, and
S W Lee, and
A Schwartz, and
H W Overbeck, and
E T Wallick
October 1991,
American journal of hypertension,
K R Whitmer, and
J H Lee, and
A F Martin, and
L K Lane, and
S W Lee, and
A Schwartz, and
H W Overbeck, and
E T Wallick
November 1991,
Zhongguo yao li xue bao = Acta pharmacologica Sinica,
K R Whitmer, and
J H Lee, and
A F Martin, and
L K Lane, and
S W Lee, and
A Schwartz, and
H W Overbeck, and
E T Wallick
June 1986,
Journal of hypertension,
K R Whitmer, and
J H Lee, and
A F Martin, and
L K Lane, and
S W Lee, and
A Schwartz, and
H W Overbeck, and
E T Wallick
June 1991,
Kidney international. Supplement,
K R Whitmer, and
J H Lee, and
A F Martin, and
L K Lane, and
S W Lee, and
A Schwartz, and
H W Overbeck, and
E T Wallick
May 1988,
Biochemical pharmacology,
K R Whitmer, and
J H Lee, and
A F Martin, and
L K Lane, and
S W Lee, and
A Schwartz, and
H W Overbeck, and
E T Wallick
October 1989,
European journal of pharmacology,
K R Whitmer, and
J H Lee, and
A F Martin, and
L K Lane, and
S W Lee, and
A Schwartz, and
H W Overbeck, and
E T Wallick
November 1998,
Biochemistry and molecular biology international,
K R Whitmer, and
J H Lee, and
A F Martin, and
L K Lane, and
S W Lee, and
A Schwartz, and
H W Overbeck, and
E T Wallick
January 1987,
Voprosy meditsinskoi khimii,
K R Whitmer, and
J H Lee, and
A F Martin, and
L K Lane, and
S W Lee, and
A Schwartz, and
H W Overbeck, and
E T Wallick
October 1987,
The American journal of physiology,
